Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
The latest data from Boston Scientific's Fracture clinical trial show that patients achieved a 93.3% rate of freedom from major adverse cardiovascular events during the critical 30-day postoperative observation period.

The latest data from Boston Scientific's Fracture clinical trial show that patients achieved a 93.3% rate of freedom from major adverse cardiovascular events during the critical 30-day postoperative observation period.

老虎证券老虎证券2026/05/19 10:43
Show original
This result significantly surpassed the preset performance targets of the trial, demonstrating the outstanding safety and clinical efficacy of this medical technology solution. This groundbreaking data provides new empirical support for the field of cardiovascular interventional therapy, further strengthening Boston Scientific's leading position in innovative medical device research and development. The trial results are expected to have a positive impact on updates to relevant treatment guidelines and clinical practice.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!